Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Abionyx Pharma Reports Q1 Gross Cash Position Of 9.0 Million Euros

April 23 (Reuters) - Abionyx Pharma SA  ABNX.PA :
    * Q1 GROSS CASH POSITION OF €9.0 MILLION AS AT MARCH 31TH,
2020
    * DELAY IN ANNOUNCEMENT OF STRATEGIC PLAN
    * CASH AND CASH EQUIVALENTS STOOD AT €9.0 MILLION AT 31
MARCH 2020
    * FINANCIAL RESOURCES COMBINED WITH TEMPORARY ABSENCE OF
FINANCIAL
COMMITMENTS RELATED TO CLINICAL DEVELOPMENTS ALLOW CO TO ADAPT
TO COVID-19

Source text for Eikon:  ID:nBw7MsfYna 
Further company coverage:  ABNX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))

Recent news on Abionyx Pharma SA

See all news